相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval
Franz X. Vollenweider et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
Effects of psilocybin on time perception and temporal control of behaviour in humans
Marc Wittmann et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Psychology, spirituality, and end-of-life care: An ethical integration?
Erin L. Moss et al.
CANADIAN PSYCHOLOGY-PSYCHOLOGIE CANADIENNE (2006)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis
E Gouzoulis-Mayfrank et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Entheogens in the study of religious experiences: Current status
WA Richards
JOURNAL OF RELIGION & HEALTH (2005)
Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): A double-blind, cross-over study in healthy volunteers
E Gouzoulis-Mayfrank et al.
PHARMACOPSYCHIATRY (2005)
Psychological and cognitive effects of long-term peyote use among Native Americans
JH Halpern et al.
BIOLOGICAL PSYCHIATRY (2005)
Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors
OL Carter et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2005)
Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil
PCR Barbosa et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2005)
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
F Hasler et al.
PSYCHOPHARMACOLOGY (2004)
Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys
WE Fantegrossi et al.
BEHAVIOURAL PHARMACOLOGY (2004)
Psilocybin impairs high-level but not low-level motion perception
OL Carter et al.
NEUROREPORT (2004)
Comparison of acute lethal toxicity of commonly abused psychoactive substances
RS Gable
ADDICTION (2004)
Hallucinogen persisting perception disorder: what do we know after 50 years?
JH Halpern et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: Implications for the neuropharmacology of cognitive deficits in schizophrenia
D Umbricht et al.
NEUROPSYCHOPHARMACOLOGY (2003)
The pharmacology of psilocybin
T Passie et al.
ADDICTION BIOLOGY (2002)
Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man
F Hasler et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Hallucinogens and redemption
MD de Rios et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2002)
Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans
E Gouzoulis-Mayfrank et al.
NEUROPSYCHOBIOLOGY (2002)
A systems model of altered consciousness: Integrating natural and drug-induced psychoses
FX Vollenweider et al.
BRAIN RESEARCH BULLETIN (2001)
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
J Riba et al.
PSYCHOPHARMACOLOGY (2001)
分享论文
